Back to the full story1 source · How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?◆ All Sources
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
1 region · 1 outlet · 1 report — every source grouped by where each outlet is based. Region reflects only headquarters, not the subject of the report.
US
1 article · 1 outlet